Determinants of Campylobacter infection and association with growth and enteric inflammation in children under 2 years of age in low-resource settings.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 11 2019
20 11 2019
Historique:
received:
22
07
2019
accepted:
31
10
2019
entrez:
22
11
2019
pubmed:
22
11
2019
medline:
4
11
2020
Statut:
epublish
Résumé
Campylobacter species infections have been associated with malnutrition and intestinal inflammation among children in low-resource settings. However, it remains unclear whether that association is specific to Campylobacter jejuni/coli. The aim of this study was to assess the association between both all Campylobacter species infections and Campylobacter jejuni/coli infections on growth and enteric inflammation in children aged 1-24 months. We analyzed data from 1715 children followed from birth until 24 months of age in the MAL-ED birth cohort study, including detection of Campylobacter species by enzyme immunoassay and Campylobacter jejuni/coli by quantitative PCR in stool samples. Myeloperoxidase (MPO) concentration in stool, used as a quantitative index of enteric inflammation, was measured. The incidence rate per 100 child-months of infections with Campylobacter jejuni/coli and Campylobacter species during 1-24 month follow up were 17.7 and 29.6 respectively. Female sex of child, shorter duration of exclusive breastfeeding, lower maternal age, mother having less than 3 living children, maternal educational level of <6 years, lack of routine treatment of drinking water, and unimproved sanitation were associated with Campylobacter jejuni/coli infection. The cumulative burden of both Campylobacter jejuni/coli infections and Campylobacter species were associated with poor growth and increased intestinal inflammation.
Identifiants
pubmed: 31748573
doi: 10.1038/s41598-019-53533-3
pii: 10.1038/s41598-019-53533-3
pmc: PMC6868199
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17124Références
BMC Vet Res. 2018 Apr 4;14(1):125
pubmed: 29618371
J Pathol. 2003 Sep;201(1):17-27
pubmed: 12950013
EBioMedicine. 2017 Apr;18:109-117
pubmed: 28396264
Vaccine. 2016 Jun 8;34(27):3068-3075
pubmed: 27154394
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S220-4
pubmed: 25305290
Lancet Glob Health. 2018 Dec;6(12):e1309-e1318
pubmed: 30287127
Popul Health Metr. 2014 Mar 21;12(1):8
pubmed: 24656134
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S193-206
pubmed: 25305287
Pediatrics. 2016 Dec;138(6):
pubmed: 27940670
Lancet. 2009 Sep 19;374(9694):1032-1035
pubmed: 19766883
J Clin Microbiol. 2014 Apr;52(4):1074-80
pubmed: 24452175
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S225-32
pubmed: 25305291
World J Gastroenterol. 2010 Sep 7;16(33):4145-51
pubmed: 20806430
Nat Rev Microbiol. 2007 Sep;5(9):665-79
pubmed: 17703225
PLoS Negl Trop Dis. 2013;7(1):e2036
pubmed: 23383356
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2291-7
pubmed: 18768495
J Epidemiol Community Health. 1999 Apr;53(4):235-8
pubmed: 10396550
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S239-47
pubmed: 25305293
PLoS One. 2018 Mar 29;13(3):e0195072
pubmed: 29596493
Am J Trop Med Hyg. 2013 Feb;88(2):390-396
pubmed: 23185075
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Clin Infect Dis. 2016 Nov 1;63(9):1171-1179
pubmed: 27501842
Am J Clin Nutr. 2017 May;105(5):1132-1138
pubmed: 28381477
Int J Epidemiol. 2003 Aug;32(4):518-26
pubmed: 12913022
PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006200
pubmed: 29415075
Clin Microbiol Rev. 2015 Jul;28(3):687-720
pubmed: 26062576
Lancet Infect Dis. 2014 Aug;14(8):716-724
pubmed: 25022434
Lancet Glob Health. 2018 Dec;6(12):e1319-e1328
pubmed: 30287125
Kurume Med J. 1998;45(1):69-73
pubmed: 9658754
Trop Med Int Health. 2018 Nov;23(11):1242-1250
pubmed: 30133067
Am J Trop Med Hyg. 2014 Jan;90(1):133-8
pubmed: 24189366